Aussie’s Pan Pharmaceuticals Gets $69 Million From U.S. In Suit
This article was originally published in PharmAsia News
Executive Summary
Customers of Australia's Pan Pharmaceuticals, closed under government orders in 2003, won $69 million in compensation in a federal court case